GlobeNewswire

TrueCommerce Acquires Datalliance

Dela

Leading vendor managed inventory service complements commerce network solutions portfolio to maximize supply chain performance

PITTSBURGH, Sept. 14, 2017 (GLOBE NEWSWIRE) -- TrueCommerce, a global provider of trading partner connectivity and integration solutions, announced today that it has acquired Datalliance, the world's largest provider of technology and services to support collaborative replenishment programs such as vendor managed inventory (VMI) and related business needs. This addition complements the TrueCommerce portfolio of offerings by providing a strategic technology service that extends its commerce network into the collaborative replenishment, inventory management and demand forecasting markets.

Omni-channel enablement changed the traditional ordering process by requiring more visibility and collaboration. VMI aligns business objectives and streamlines supply chain operations for both suppliers and their supply chain partners. Trading partners focused on collaboration through VMI programs are expanding at a rapid rate, using better demand signals, optimizing shipping and distribution to increase profitability and automating more of the replenishment process to drive efficiency and reduce costs. Datalliance VMI solutions allow them to scale their programs to cover more categories, more geographies, more partners and increase sales.

"Our global growth strategy is founded on increasing the breadth and depth of the services that we offer to our commerce network community," said Mike Cornell, CEO of TrueCommerce. "The addition of industry leader Datalliance and their collaborative replenishment, inventory management and demand forecasting capabilities increases the value that we add for our customers, allows us access to markets that we previously didn't have and enhances our competitive position."

Datalliance is a pioneer in offering VMI as a cloud-based platform and have successfully implemented VMI for hundreds of customers across multiple industries, geographies and business sizes.

"We are very excited about the opportunity to join forces with TrueCommerce and the potential to create new paths to market together," said Carl Hall, President and CEO of Datalliance.

"With our strategic direction to expand our commerce network offerings to adjacent, yet related solutions, we recognize the importance of vendor managed inventory as a tool to optimize order processing and collaboration between suppliers and their partners," adds Cornell. "This acquisition follows the announcement of the acquisition of HighJump Software, sister company to TrueCommerce, by Körber AG. Parent company, Accellos Holdings and its primary investor, Accel-KKR will retain TrueCommerce. The sale of HighJump allows TrueCommerce to continue to invest aggressively to grow and expand its global commerce network, as exemplified by the acquisition of Datalliance."

For more information please refer to the frequently asked questions (FAQs).

About Datalliance  

Datalliance is the world's largest provider of technology and services to support collaborative replenishment programs such as Vendor Managed Inventory (VMI) and related approaches.  Delivered as a cloud-based platform backed by extensive customer care, Datalliance makes it easy for trading partners to establish inventory management relationships that increase sales and profits by fully aligning business objectives, increasing on-shelf availability, optimizing turns, and reducing supply chain costs.  Datalliance manages billions of dollars in orders, millions of SKUs, and tens of thousands of locations worldwide for leading companies in consumer and industrial markets. For more information about Datalliance, visit www.datalliance.com.

About TrueCommerce

TrueCommerce revolutionizes trading partner connectivity by linking suppliers, retail hubs and end consumers in one global commerce network.

With our flexible, integrated and fully managed service solutions, customers of any size can easily connect with any trading partner while enjoying the peace of mind of a proven service platform that reliably handles tens of millions of transactions annually without the need for any customer interaction.

From the factory to the warehouse, from distributor to retail storefront, achieve new levels of business connectivity and performance with the world's most complete trading partner platform.

TrueCommerce: Connect. Integrate. Accelerate.

For more information, visit http://www.truecommerce.com.

Media Contact 
Yegor Kuznetsov
TrueCommerce 
1-703-209-0167
yegor.kuznetsov@highjump.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Datalliance via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Stillfront Group rekryterar ansvarig för M&A19.12.2018 12:07Pressmeddelande

PRESSMEDDELANDE 19 december, 2018 Stillfront Group rekryterar ansvarig för M&A Stillfront Group, en marknadsledare inom 'free to play' online strategispel, annonserar idag att Marina Andersson har utsetts till ansvarig för M&A och kommer att ingå i koncernledningen. Marina har närmare tjugo års erfarenhet från investment banking och M&A. Hon har omfattande erfarenhet inom strategisk och finansiell rådgivning, affärsgenerering, projektledning inom förvärv och försäljningar av företag, finansiell analys, due diligence, samt företagsvärdering. Tidigare positioner inkluderar: Director, Deloitte's Corporate Finance Advisory team, Director, ICECAPITAL Securities, Associate Partner och Investment Manager, Deseven, samt M&A Analytiker på Carnegie. Marina har två magister-examen från Stockholms universitet och Russian Herzen State Pedagogical University. "Förvärv är en viktig del av Stillfronts affärsstrategi och vi är mycket glada att rekrytera Marina Andersson. Marinas breda erfarenhet och pr

Stillfront Group announces Head of M&A19.12.2018 12:07Pressmeddelande

PRESS RELEASE December 19, 2018 Stillfront Group announces Head of M&A Stillfront Group, a market leader in 'free to play' online strategy games, today announces that Marina Andersson has been appointed as Head of M&A and will be part of the Group's management team. Marina has close to 20 years track record of investment banking and M&A. She has extensive competence within strategic and financial advisory, deal generation, buy and sell side M&A project management, financial analysis, due diligence and company valuation. Former positions include: Director at Deloitte's Corporate Finance Advisory team, Director at ICECAPITAL Securities, Associate Partner and Investment Manager at Deseven, M&A Analyst at Carnegie. She holds two Master degrees from Stockholm University and Russian Herzen State Pedagogical University. "Acquisitions are a crucial part of Stillfront's business strategy and we are very pleased with the appointment of Marina Andersson. Marina's breadth of experience and profess

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum